Leslie Caron CRCN Inserm

Identifiants chercheurs

IdHAL :

leslie-caron

IdRef :

086156810

ResearcherID :

AAE-3511-2022

Publications

Article dans une revue (5)

In skeletal muscle and neural crest cells, SMCHD1 regulates biological pathways relevant for Bosma syndrome and facioscapulohumeral dystrophy phenotype Camille Laberthonnière,Mégane Delourme,Raphaël Chevalier,Camille Dion,Benjamin Ganneet al. Nucleic Acids Research, 2023, 51 (14), pp.7269-7287. ⟨10.1093/nar/gkad523⟩ Article dans une revue hal-04134959v1
I.09 Induced pluripotent stem cells for modeling neuromuscular disorders: development of disease-specific assays, live cells functional testing and drug design Mégane Delourme,Camille Laberthonnière,Stefano Testa,Leslie Caron,Frédérique Magdinier Neuromuscular Disorders, 2022, 32, pp.S95. ⟨10.1016/j.nmd.2022.07.221⟩ Article dans une revue hal-04033677v1
Regulation of ES Cell Lineage Commitment by Mitogen Activated Protein Kinases Bernard Binetruy,Lynn Heasley,Frédéric Bost,Leslie Caron,Myriam Aouadi Stem cells (Dayton, Ohio), 2007, pp.24. ⟨10.1634/stemcells.2006-0612⟩ Article dans une revue inserm-00128753v1
The extracellular signal-regulated kinase isoform ERK1 is specifically required for in vitro and in vivo adipogenesis. Frédéric Bost,Myriam Aouadi,Leslie Caron,Patrick C. Even,Nathalie Belmonteet al. Diabetes, 2005, 54 (2), pp.402-11 Article dans une revue hal-00321945v1
The role of MAPKs in adipocyte differentiation and obesity. Frédéric Bost,Myriam Aouadi,Leslie Caron,Bernard Binétruy Biochimie, 2005, 87 (1), pp.51-6. ⟨10.1016/j.biochi.2004.10.018⟩ Article dans une revue inserm-00000011v1

Communication dans un congrès (1)

Modelling LAMA2-CMD to explore physiopathology and therapeutic options Leslie Caron,Allamand V EJPRD Workshop: LAMA2-Muscular Dystrophy: Paving the road to therapy, Mar 2023, Barcelone, Spain. pp.16-22, ⟨10.1016/j.nmd.2024.01.001⟩ Communication dans un congrès hal-04475069v1

Proceedings/Recueil des communications (1)

European Joint Programme on Rare Diseases workshop: LAMA2-muscular dystrophy: paving the road to therapy March 17–19, 2023, Barcelona, Spain Hubert Smeets,Bram Verbrugge,Xavier Bulbena,Liliya Hristova,Julia Vogtet al. LAMA2-muscular dystrophy: paving the road to therapy, Neuromuscular Disorders, 36, pp.16 - 22, 2024, ⟨10.1016/j.nmd.2024.01.001⟩ Proceedings/Recueil des communications hal-04546346v1